SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-096621
Filing Date
2016-02-12
Accepted
2016-02-12 16:32:01
Documents
44
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q a16-2034_110q.htm 10-Q 528456
2 EX-31.1 a16-2034_1ex31d1.htm EX-31.1 12557
3 EX-32.1 a16-2034_1ex32d1.htm EX-32.1 5883
  Complete submission text file 0001104659-16-096621.txt   2997412

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ctrv-20151231.xml EX-101.INS 517315
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctrv-20151231.xsd EX-101.SCH 39241
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctrv-20151231_cal.xml EX-101.CAL 24857
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctrv-20151231_def.xml EX-101.DEF 143921
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ctrv-20151231_lab.xml EX-101.LAB 322817
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctrv-20151231_pre.xml EX-101.PRE 234019
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36856 | Film No.: 161419800
SIC: 2834 Pharmaceutical Preparations